High LGMN expression in numerous malignant tumor cells has been found to alter prognosis (Lin et al., 2014; Poreba et al., 2016), and several studies have demonstrated that patients with high LGMN expression have a lower relative survival. This evidence concerns the gene LGMN and neoplasm.